Respecta® Balance Gel* (MD)

For vaginal health and balance.

Marketing tools Women's health

Download the brochure

Product background

Respecta® Balance Gel is a medical device adjuvant in the treatment of vaginitis and vaginosis specifically studied for rebalancing the physiological pH and vaginal microbiota.
The vaginal environment is populated by numerous bacterial species (such as lactobacilli, gardnerella, streptococci, etc.) that in physiological conditions are in balance (eubiosis) with a clear prevalence of lactobacilli. However, this fine balance can be altered by several factors including antibiotic consumption, use of overly aggressive cleansers, irritative or allergic conditions. Consequently, potentially pathogenic microorganisms such as Candida and Gardnerella take over the Lactobacillus population, creating a state of dysbiosis up to causing pathological conditions such as bacterial vaginosis, aerobic vaginitis, or vulva-vaginitis caused by Candida spp. (VVC). In particular, in the case of dysbiosis, vaginal pH often increases creating a vicious circle with a progressive reduction of the defenses of the vaginal mucosa.

Respecta® Balance Gel is suitable for restoring the physiological vaginal pH, favoring the proliferation and growth of beneficial microorganisms (lactobacilli) that normally colonize healthy tissue.

Key ingredients

Glycogen, prebiotic fiber, hyaluronic acid, and lactic acid.

Target

  • Vaginal dysbiosis
  • Bacterial and yeast infections

Benefits and features

  • Restores physiological vaginal pH
  • Promotes the growth of beneficial microorganism
  • Provides hydration and protection to the vaginal tissue
  • Promotes the formation of protective biofilm
  • Works well in combination with standard oral drug/probiotic treatment

Scientific evidence and proprietary studies

In vitro mechanistic study.
Effects of Farnesol on Drug-Resistant and Non-Resistant Candida albicans: Implications for Cosmetic and Pharmaceutical Applications (Yar et al 2020).
In Vitro Exploration of Probiotic Bacteria Interactions with Candida Using Culture Techniques to Model Dysbiotic Conditions in Colonized Tissues (Wittman et al 2021).

*Registered as “Respecta® Gel Vaginale (NB 0476)”.

RELATED PRODUCTS


Marketing tools Women's health

Download the brochure
Product name Respecta® Balance Gel*
Status Medical device class IIa
Key ingredients Glycogen, prebiotic fiber, hyaluronic acid and lactic acid
Target and indication Adjuvant in the treatment of vaginitis and vaginosis
Claims EFSA n. a.
Scientific evidence and study Mechanistic study
Pharmaceutical form Gel (single-use tubes or tube with vaginal applicator)

Are you interested in this product?

We respond to any technical or commercial request:




    SUBSCRIBE TO OUR NEWSLETTER

    Stay updated on news

    * indicates required

    The contents of this page of the website, and concerning Medical Devices only, are intended exclusively for healthcare professionals.
    The information contained herein is reserved exclusively for healthcare professionals.
    In order to consult the information contained herein, I declare under my responsibility to belong to this professional category. With reference to the circular integration of 03/23/2006, issued on 04/20/2010 by the Ministry of Health, concerning the advertising on Medical Devices, consultation of the contents of the website are reserved exclusively for doctors, pharmacists and other healthcare operators.